KALARIS THERAPEUTICS INC

$KLRS
← All companies Sign in to track
Institutional coverage

51 13F filers hold $KLRS.

13F holders
51
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

4 holders · Q1 2026

$KLRS is held by 4 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.03%, with an average of 0.01% of portfolio. Largest holder: ADAR1 Capital Management, LLC at 0.03%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

01
ADAR1 Capital Management, LLC
0.03% held
α +74.0pts
02
Johnson Financial Group, Inc.
0.00% held
α +14.7pts
03
Connor, Clark & Lunn Investment Management Ltd.
0.00% held
α +12.3pts
04
Citigroup Inc.
0.00% held
α +26.3pts

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 51 · Source: 13F-HR
01
Castleview Partners, LLC
7.26% of portfolio
12,948,081 sh
02
Samsara BioCapital, LLC
8.66% of portfolio
11,448,081 sh
03
Wealth Dimensions Group, Ltd.
0.08% of portfolio
700,000 sh
04
Confluence Investment Management LLC
0.01% of portfolio
572,687 sh
05
GSG Advisors LLC
0.07% of portfolio
435,798 sh
06
Liberty Wealth Management LLC
0.17% of portfolio
360,000 sh
07
Owen LaRue, LLC
1.08% of portfolio
295,771 sh
08
Loomis Sayles & Co. L P
—
223,774 sh
09
Callan Capital, LLC
0.01% of portfolio
184,522 sh
10
Jupiter Wealth Management LLC
—
100,000 sh
See all 51 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $KLRS in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $KLRS in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:27 UTC.